FDA to Hold Call Discussing Potential Issues with Pfizer's (PFE) Stop-Smoking Drug, Chantix -CNBC
More News related to PFE
- Trading Outlook for Advanced Life Sciences Holdings Inc. Issued by InvestorSoup.com
- Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX(R) (Varenicline) Compared With Placebo
- Flamel Technologies Announces Licensing Agreement with Pfizer
- Pfizer (PFE) And Medivation (MDVN) Initiate Two Phase 3 Trials Of Dimebon
- Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer's Disease
According to CNBC's Mike Huckman, a Pfizer (NYSE: PFE) spokesperson has said that the FDA will hold a 12:30pm ET call related to the possible issues of the company's stop-smoking drug, Chantix.
Related Categories
FDARumors
Stocks Mentioned
-0.06Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
